Literature DB >> 26712582

Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease.

Yoshinori Ito1, Michio Suzuki2, Jun-ichi Kawada2, Hiroshi Kimura3.   

Abstract

Chronic active Epstein-Barr virus disease (CAEBV) is a distinct EBV-associated lymphoproliferative disease with a poor prognosis. Although the viral load in blood samples has been widely used for diagnosing CAEBV, well-defined viral load thresholds to guide clinicians are currently lacking. The aim of the present study was to determine standardized diagnostic values for EBV load in blood samples of CAEBV patients using the World Health Organization international standard for reporting. Levels of EBV DNA in 103 peripheral blood mononuclear cells (PBMCs) and 95 plasma/serum samples from 107 cases with CAEBV were quantified and expressed in international units. Receiver operating characteristic curves were analyzed to assess the most appropriate cut-off values for levels of EBV DNA to distinguish CAEBV from EBV-associated infectious mononucleosis (IM) and controls with past EBV infection. Levels of EBV DNA in PBMCs were significantly higher in the CAEBV group (median, 10(4.2) IU/μgDNA) compared to the IM (median, 10(2.1) IU/μgDNA) and control groups. An inconsistent qualitative result was seen in 13 of 86 CAEBV patients; in these, EBV-DNA was positive in PBMCs, but negative in plasma. Diagnostic cut-off values for viral load in PBMCs from CAEBV patients, as compared to those of healthy controls and IM patients, were 10(2.0) IU/μgDNA and 10(3.2) IU/μgDNA, respectively. For diagnostic purposes, the viral load of PBMCs was better than of plasma/serum. A diagnostic cut-off EBV load for CAEBV may be useful for the management of CAEBV patients.
Copyright © 2015 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CAEBV; Chronic active Epstein–Barr virus disease; Diagnosis; Peripheral blood mononuclear cells; Viral load

Mesh:

Substances:

Year:  2015        PMID: 26712582     DOI: 10.1016/j.jiac.2015.11.002

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  8 in total

1.  Associations of Epstein-Barr Virus DNA in PBMCs and the Subtypes with Breast Cancer Risk.

Authors:  Wei Zhang; Min-Yi Wang; Xue-Ling Wei; Ying Lin; Feng-Xi Su; Xiao-Ming Xie; Lu-Ying Tang; Ze-Fang Ren
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

2.  Correlation between Epstein-Barr Virus Infection and Disease Activity of Systemic Lupus Erythematosus: a Cross-Sectional Study

Authors:  Ahmad Piroozmand; Hamed Haddad Kashani; Batool Zamani
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

3.  Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.

Authors:  Pengfei Cao; Meili Zhang; Wei Wang; Yafei Dai; Buqing Sai; Jun Sun; Lujuan Wang; Fan Wang; Guiyuan Li; Juanjuan Xiang
Journal:  BMC Infect Dis       Date:  2017-05-03       Impact factor: 3.090

4.  Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases.

Authors:  Peiling Zhang; Chen Zeng; Jiali Cheng; Jing Zhou; Jia Gu; Xia Mao; Wei Zhang; Yang Cao; Hui Luo; Bin Xu; Qinlu Li; Min Xiao; Jianfeng Zhou
Journal:  Open Forum Infect Dis       Date:  2019-04-04       Impact factor: 3.835

Review 5.  Chronic Active Epstein-Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods.

Authors:  Ayako Arai
Journal:  Microorganisms       Date:  2021-01-15

6.  Case Report: Chronic Active Epstein-Barr Virus Infection With Subcutaneous Nodules and Systemic Damage.

Authors:  Huating Luo; Zhe Yuan; Bo Qin
Journal:  Front Med (Lausanne)       Date:  2022-03-31

7.  The Outcome of Induction Therapy for EBV-Related Hemophagocytic Lymphohistiocytosis: A Model for Risk Stratification.

Authors:  Tingting Cui; Jingshi Wang; Zhao Wang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

8.  Clinical value of plasma and peripheral blood mononuclear cells Epstein-Barr Virus DNA dynamics on prognosis of allogeneic stem cell transplantation.

Authors:  Xi Zhou; Xuan Lu; Jing He; Ziwei Xu; Qian Li; Pian Ye; Zhaodong Zhong; Wei Shi; Han Yan; Yong You; Yu Hu; Huafang Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-16       Impact factor: 6.073

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.